Asset Details
Do you wish to reserve the book?
Amyotrophic Lateral Sclerosis, Lead, and Genetic Susceptibility: Polymorphisms in the δ-Aminolevulinic Acid Dehydratase and Vitamin D Receptor Genes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Amyotrophic Lateral Sclerosis, Lead, and Genetic Susceptibility: Polymorphisms in the δ-Aminolevulinic Acid Dehydratase and Vitamin D Receptor Genes
Do you wish to request the book?
Amyotrophic Lateral Sclerosis, Lead, and Genetic Susceptibility: Polymorphisms in the δ-Aminolevulinic Acid Dehydratase and Vitamin D Receptor Genes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Amyotrophic Lateral Sclerosis, Lead, and Genetic Susceptibility: Polymorphisms in the δ-Aminolevulinic Acid Dehydratase and Vitamin D Receptor Genes
2003
Overview
Previous studies have suggested that lead exposure may be associated with increased risk of amyotrophic lateral sclerosis (ALS). Polymorphisms in the genes for δ-aminolevulinic acid dehydratase (ALAD) and the vitamin D receptor (VDR) may affect susceptibility to lead exposure. We used data from a case-control study conducted in New England from 1993 to 1996 to evaluate the relationship of ALS to polymorphisms in ALAD and VDR and the effect of these polymorphisms on the association of ALS with lead exposure. The ALAD 2 allele (177G to C; K59N) was associated with decreased lead levels in both patella and tibia, although not in blood, and with an imprecise increase in ALS risk [odds ratio (OR) = 1.9; 95% confidence interval (95% CI), 0.60-6.3]. We found a previously unreported polymorphism in ALAD at an Msp1 site in intron 2 (IVS2+299G>A) that was associated with decreased bone lead levels and with an imprecise decrease in ALS risk (OR = 0.35; 95% CI, 0.10-1.2). The VDR B allele was not associated with lead levels or ALS risk. Our ability to observe effects of genotype on associations of ALS with occupational exposure to lead or with blood or bone lead levels was limited. These findings suggest that genetic susceptibility conferred by polymorphisms in ALAD may affect ALS risk, possibly through a mechanism related to internal lead exposure.
Publisher
National Institute of Environmental Health Sciences. National Institutes of Health. Department of Health, Education and Welfare,National Institute of Environmental Health Sciences
Subject
Amyotrophic Lateral Sclerosis - chemically induced
/ Amyotrophic Lateral Sclerosis - genetics
/ DNA - isolation & purification
/ Genetic Predisposition to Disease
/ Genotype
/ Humans
/ Porphobilinogen Synthase - drug effects
/ Porphobilinogen Synthase - genetics
